Variability of hepatitis E serologic assays in a pediatric liver transplant recipient: Challenges to diagnosing hepatitis E virus infection in the United States

Transplant Infectious Disease

Volumn 17, Issue 2, 2015, Pages 284-288

  Sue, P K ^a   Pisanic, N ^b   Heaney, C D ^b   Mixson Hayden, T ^c   Kamili, S ^c   Nelson, K ^b   Schwarz, K B ^a   Forman, M ^a   Valsamakis, A ^a   Ticehurst, J ^a,b   Karnsakul, W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Hepatitis E virus; Liver transplantation; Viral diagnostics

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; MEPREDNISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; HEPATITIS ANTIBODY; IMMUNOSUPPRESSIVE AGENT; VIRUS RNA;

ABDOMINAL PAIN; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILE DUCT ATRESIA; BILIARY STENT; CASE REPORT; CHILD; CHILDHOOD DISEASE; CLINICAL EVALUATION; CONCENTRATION RESPONSE; CYTOMEGALOVIRUS; CYTOPATHOGENIC EFFECT; DIAGNOSTIC TEST; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; ECHOGRAPHY; FECES ANALYSIS; FEVER; GASTROINTESTINAL SYMPTOM; GRAFT RECIPIENT; HEPATIC ARTERY; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HUMAN TISSUE; HYPERTRANSAMINASEMIA; IDIOPATHIC DISEASE; JAUNDICE; LABORATORY; LABORATORY TEST; LETHARGY; LIVER BIOPSY; LIVER TRANSPLANTATION; LIVER VEIN; LIVER VEIN OBSTRUCTION; MEDICAL HISTORY; NAUSEA; OPEN READING FRAME; PATIENT CARE; POLYMERASE CHAIN REACTION; PORTAL VEIN; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; STEROID THERAPY; UNITED STATES; VIREMIA; VIRUS HEPATITIS; BILIARY ATRESIA; BLOOD; FEMALE; GRAFT REJECTION; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; PUBLIC HEALTH SERVICE; STANDARDS;

BILIARY ATRESIA; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; RNA, VIRAL; SEROLOGIC TESTS; UNITED STATES;

EID: 84925345118     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12366     Document Type: Article

References (19)

1. Dalton H, Bendall R. Hepatitis E: an emerging infection in developed countries. Lancet 2008; 8: 697-709.
2. Nelson K, Kmush B, Labrique A. The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients. Expert Rev Anti Infect 2011; 9 (3): 1133-1148.
3. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358 (8): 811-817.
4. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet 2012; 379: 2477-2488.
5. Kamar N, Garrosie C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140: 1481-1489.
6. Kuniholm M, Purcell R, McQuillan G, Engle R, Wasley A, Nelson K. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009; 200: 48-56.
7. Drobeniuc J, Montfort T, Le NT, et al. Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012. Emerg Infect Dis 2013; 19 (2): 218-222.
8. Teshale E, Denniston M, Drobeniuc J, Kamili S, Chong-Gee T, Holmberg SD, Decline in hepatitis E virus antibody prevalence in the United States from 1988-1994 to 2009-2010. J Infect Dis 2015; 211 (3): 366-373.
9. Te HS, Drobeniuc J, Kamili S, Dong C, Hart J, Sharapov UM. Hepatitis E virus infection in a liver transplant recipient in the United States: a case report. Transplant Proc 2013; 45 (2): 810-813.
10. Yoo N, Bernstein C, Caldwell C, et al. Hepatitis E virus infection in a liver transplant recipient: delayed diagnosis due to variable performance of serologic assays. Transpl Infect Dis 2013; 15: E166-E168.
11. Jothikumar N, Cromeans TL, Robertson BH, et al. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods 2006; 131 (1): 65-71.
12. Mokhtari C, Marchadier E, Haim-Boukobza S, et al. Comparison of real-time RT-PCR assays for hepatitis E virus RNA detection. J Clin Virol 2013; 58: 36-40.
13. Legrand-Abravanel F, Kamar N, Sandres-Saune K, et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 2010; 202: 835-844.
14. Kamar N, Izopet J, Tripon S, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med 2014; 370 (12): 1111-1120.
15. Pas S, Streefkerk R, Pronk M, et al. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J Clin Virol 2013; 58: 629-634.
16. Khudyakov Y, Kamili S. Serological diagnostics of hepatitis E virus infection. Virus Res 2011; 161: 84-92.
17. Drobeniuc J, Meng J, Reuter G, et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010; 51 (3): 175-186.
18. Ge SX, Zheng YJ, Guo QS, et al. Evaluation of two anti hepatitis E virus kits. Biomed Environ Sci 2007; 20: 512-515.
19. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG Kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010; 82: 799-805.